2009
DOI: 10.1021/jm900187v
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in the Development of Polyamine Analogues as Antitumor Agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
114
0
10

Year Published

2010
2010
2015
2015

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 156 publications
(125 citation statements)
references
References 159 publications
1
114
0
10
Order By: Relevance
“…Previously, polyamine analogues were designed, synthesized, and tested as anticancer agents (Casero and Woster 2009) as well as in neurodegenerative processes (Minarini et al 2010), antiparasitic compounds, neurotransmitter receptor neuroprotectants, and multitargetdirected ligands for multifactorial diseases. Murray- Stewart et al (2013) report the effects of an antitumor polyamine analogue as an inhibitor of LSD1 in acute myeloid leukemia (AML).…”
Section: Editorialmentioning
confidence: 99%
“…Previously, polyamine analogues were designed, synthesized, and tested as anticancer agents (Casero and Woster 2009) as well as in neurodegenerative processes (Minarini et al 2010), antiparasitic compounds, neurotransmitter receptor neuroprotectants, and multitargetdirected ligands for multifactorial diseases. Murray- Stewart et al (2013) report the effects of an antitumor polyamine analogue as an inhibitor of LSD1 in acute myeloid leukemia (AML).…”
Section: Editorialmentioning
confidence: 99%
“…Therefore, they can bind to the negatively charged nucleic acid either by electrostatic interactions and/or by hydrogen bonding. [16][17][18][19][20][21] Several other polycationic dendrimers such as poly(amidoamine) and poly(propyleneimine) have been synthesised. [22][23][24] Due to their unique one-dimensional structure and remarkable mechanical, thermal, optical and electronic properties, carbon nanotubes (CNTs), [25][26][27][28][29][30] can be considered as attractive candidates in diverse nanotechnological applications ranging from molecular electronics and quantum computing to materials science and biomedicine.…”
Section: Introductionmentioning
confidence: 99%
“…These compounds, together with the enzymes involved in their biosynthesis, are present at high levels in rapidly proliferating cells, including cancer cells and protozoan parasites Casero and Woster, 2009). The physiological roles of polyamines are not completely understood (Jänne et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, there is significant interest in targeting polyamine synthesis as a basis for chemotherapy; e.g. the polyamine biosynthesis inhibitor -difluoromethylornithine (DFMO, Ornidyl) is used for the treatment of West African sleeping sickness caused by the parasite Trypanosoma brucei gambiense (Bacchi et al, 1990), and DFMO is also under investigation as an anticancer agent (Casero and Woster, 2009). …”
Section: Introductionmentioning
confidence: 99%